About Comofi Medtech Private Limited
Data last updated: 08 February 2026
Comofi Medtech Private Limited is a private limited company based in Bangalore, Karnataka, India, a subsidiary of Comofi Innovations Private Limited and recognised as a startup by DPIIT. It specialises in diagnostic centers and pathology labs, a part of the broader healthcare sector. Incorporated on 17 January 2018, the company has been in operation for over 8 years.
Registered with ROC Bangalore under CIN U33309KA2018PTC109614.
Capital: an authorised share capital of ₹10.5 Lakh and a paid-up capital of ₹3.29 Lakh. It is led by directors including Satish Dnyanoba Kalme and Raghunath Sarakanur Krishnappa.
Last AGM: 30 September 2023. Financial statements filed for year ended 31 March 2023. Office: 358/1644/37/4/13 Jakkur Road Shivanahalli Village Yelahanka Hobli Bangalore North Taluk, Karnataka, India – 560064.
It operates as a subsidiary of Comofi Innovations Private Limited.
The company is associated with 1 brand - Comofi Medtech.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website comofimedtech.com.
-
Email*****@*****.com
-
Telephone+91-****-******
-
Website
-
Social Media
-
Registered Address358/1644/37/4/13 Jakkur Road Shivanahalli Village Yelahanka Hobli Bangalore North Taluk, Karnataka, India – 560064
-
IndustryHealthcare, Diagnostic Centers & Pathology Labs
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with Comofi Medtech Private Limited
Comofi Medtech Private Limited operates one associated brand: Comofi Medtech. These brands represent Comofi Medtech Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| AI and AR-based assistive robots for surgery are developed. | comofimedtech.com |
Competitors & Alternatives of Comofi Medtech Private Limited
Brands and companies operating in the same space as Comofi Medtech Private Limited include Brainlab, PROCEPT BioRobotics, Caresyntax and 7 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
|
|
Software and integrated solutions for surgical and radiotherapy applications | Munich, Germany, Germany | 1989 |
|
|
Robotic waterjet system for prostate tissue removal is developed. | Redwood City, United States, United States | 2009 |
|
|
Surgical outcomes are enhanced via analytics and integration platform. | Boston, United States, United States | 2013 |
|
|
Robotic microsurgical systems for endoscopy are developed. | Redwood City, United States, United States | 2007 |
|
|
Augmented reality systems for guiding surgical procedures are developed. | Yokneam Illit, Israel, Israel | 2014 |
|
|
A robotic platform is used for microsurgery with scaled instruments. | Calci, Italy, Italy | 2015 |
|
|
Software and hardware solutions for MRI-guided surgical planning are provided. | Irvine, United States, United States | 1998 |
|
|
Robotic laparoscopic systems are developed for minimally invasive surgeries. | Durham, United States, United States | 2006 |
|
|
Robotic-assisted surgical systems are developed for minimally invasive procedures. | Sunnyvale, United States, United States | 1995 |
|
|
Robotic guidance systems for dental implantation surgeries are provided. | Miami, United States, United States | 2012 |
Business Activity of Comofi Medtech Private Limited
Comofi Medtech Private Limited operates primarily in the professional, scientific and technical sector. The company has 1 registered business activity segment, reflecting its diverse operational portfolio.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| ********* | Professional, Scientific and Technical | ********* | Other professional, scientific and technical activities | ********* |
Auditor Details of Comofi Medtech Private Limited
Comofi Medtech Private Limited is audited by M.V.RAO & ASSOCIATES for the financial year 2023. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M.V.RAO & ASSOCIATES | blur-value | blur-value | blur-value |
Board of Directors of Comofi Medtech Private Limited
Comofi Medtech Private Limited is currently managed by 3 directors, with 2 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Satish Dnyanoba Kalme | Director | 17 Jan 2018 | 8 Years 5 Months | Current |
| Raghunath Sarakanur Krishnappa | Director | 17 Jan 2018 | 8 Years 5 Months | Current |
|
Abhay Uttamchand Jain
Also directs:
Divine Wealth Advisory Llp, Neon Laboratories Limited, Surajlok Chemicals Private Limited and 4 more
|
Director | 10 Jun 2021 | 5 Years 1 Months | Current |
Financials of Comofi Medtech Private Limited FY 2023 filings available
Comofi Medtech Private Limited reported revenue of ₹- (down -100.00% YoY) for FY 2023. Profit growth despite declining revenue indicates effective cost management and margin discipline.
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue from Operations | ***** | ***** | ***** | ***** | ***** |
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Other Income | ***** | ***** | ***** | ***** | ***** |
| Total Revenue | ***** | ***** | ***** | ***** | ***** |
| Expenses | |||||
| Total Expenses | ***** | ***** | ***** | ***** | ***** |
| Raw Material Cost | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory FG | ***** | ***** | ***** | ***** | ***** |
| Change in Inventory WIP | ***** | ***** | ***** | ***** | ***** |
| Purchase of Traded Goods | ***** | ***** | ***** | ***** | ***** |
| Employee Cost | ***** | ***** | ***** | ***** | ***** |
| Managerial Remuneration | ***** | ***** | ***** | ***** | ***** |
| Audit Fees | ***** | ***** | ***** | ***** | ***** |
| Insurance | ***** | ***** | ***** | ***** | ***** |
| Power & Fuel | ***** | ***** | ***** | ***** | ***** |
| Interest | ***** | ***** | ***** | ***** | ***** |
| Depreciation | ***** | ***** | ***** | ***** | ***** |
| Other Expenses | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| EBITDA (Operating Profit) | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| Exceptional Items | ***** | ***** | ***** | ***** | ***** |
| Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Exceptional & Extraordinary Items | ***** | ***** | ***** | ***** | ***** |
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Tax & Net Profit | |||||
| Tax Expense | ***** | ***** | ***** | ***** | ***** |
| Current Tax | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax | ***** | ***** | ***** | ***** | ***** |
| Profit from Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Tax on Discontinued Operations | ***** | ***** | ***** | ***** | ***** |
| Profit | ***** | ***** | ***** | ***** | ***** |
| Net Margin % | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Shareholders' Funds | |||||
| Total Shareholders' Funds | ***** | ***** | ***** | ***** | ***** |
| Equity Capital | ***** | ***** | ***** | ***** | ***** |
| Reserves & Surplus | ***** | ***** | ***** | ***** | ***** |
| Money Against Warrants | ***** | ***** | ***** | ***** | ***** |
| Other Equity | ***** | ***** | ***** | ***** | ***** |
| Non-Current Liabilities | |||||
| Total Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Liabilities | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Long-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Current Liabilities | |||||
| Total Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Borrowings | ***** | ***** | ***** | ***** | ***** |
| Trade Payables | ***** | ***** | ***** | ***** | ***** |
| Other Current Liabilities | ***** | ***** | ***** | ***** | ***** |
| Short-Term Provisions | ***** | ***** | ***** | ***** | ***** |
| Total Equity & Liabilities | ***** | ***** | ***** | ***** | ***** |
| Non-Current Assets | |||||
| Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Tangible Assets | ***** | ***** | ***** | ***** | ***** |
| Intangible Assets | ***** | ***** | ***** | ***** | ***** |
| Capital WIP | ***** | ***** | ***** | ***** | ***** |
| Intangibles Under Dev | ***** | ***** | ***** | ***** | ***** |
| Investments | ***** | ***** | ***** | ***** | ***** |
| Deferred Tax Assets | ***** | ***** | ***** | ***** | ***** |
| LT Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Non-Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Assets | |||||
| Current Assets | ***** | ***** | ***** | ***** | ***** |
| Current Investments | ***** | ***** | ***** | ***** | ***** |
| Inventories | ***** | ***** | ***** | ***** | ***** |
| Trade Receivables | ***** | ***** | ***** | ***** | ***** |
| Cash & Bank Balance | ***** | ***** | ***** | ***** | ***** |
| ST Loans & Advances | ***** | ***** | ***** | ***** | ***** |
| Other Current Assets | ***** | ***** | ***** | ***** | ***** |
| Total Assets | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Cash from Operating Activities (CFO) | |||||
| Profit Before Tax | ***** | ***** | ***** | ***** | ***** |
| Non-Cash Adjustments | ***** | ***** | ***** | ***** | ***** |
| + Interest Expense | ***** | ***** | ***** | ***** | ***** |
| + Depreciation | ***** | ***** | ***** | ***** | ***** |
| +/- Unrealized Forex | ***** | ***** | ***** | ***** | ***** |
| - Dividend Income | ***** | ***** | ***** | ***** | ***** |
| - Interest Income | ***** | ***** | ***** | ***** | ***** |
| +/- Other Non-Cash Items | ***** | ***** | ***** | ***** | ***** |
| Changes in Working Capital | ***** | ***** | ***** | ***** | ***** |
| +/- Inventory | ***** | ***** | ***** | ***** | ***** |
| +/- Debtors | ***** | ***** | ***** | ***** | ***** |
| +/- Creditors | ***** | ***** | ***** | ***** | ***** |
| Reconciliation Adjustments | ***** | ***** | ***** | ***** | ***** |
| Cash Generated from Operations | ***** | ***** | ***** | ***** | ***** |
| Income Taxes Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFO (Cash from Operations) | ***** | ***** | ***** | ***** | ***** |
| Cash from Investing Activities (CFI) | |||||
| Acquisitions & Disposals | ***** | ***** | ***** | ***** | ***** |
| Disposal of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Acquisition of Subsidiaries | ***** | ***** | ***** | ***** | ***** |
| Capex | ***** | ***** | ***** | ***** | ***** |
| Purchase of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Sale of Fixed Assets | ***** | ***** | ***** | ***** | ***** |
| Other Investing Cash Flows | ***** | ***** | ***** | ***** | ***** |
| Net CFI (Cash from Investing) | ***** | ***** | ***** | ***** | ***** |
| Cash from Financing Activities (CFF) | |||||
| Equity Issuance | ***** | ***** | ***** | ***** | ***** |
| Debt Raised | ***** | ***** | ***** | ***** | ***** |
| Debt Repaid | ***** | ***** | ***** | ***** | ***** |
| Dividends Paid | ***** | ***** | ***** | ***** | ***** |
| Interest Paid | ***** | ***** | ***** | ***** | ***** |
| Net CFF (Cash from Financing) | ***** | ***** | ***** | ***** | ***** |
| Net Cash Position | |||||
| Net Change in Cash (Pre-Forex) | ***** | ***** | ***** | ***** | ***** |
| Closing Cash & Equivalents | ***** | ***** | ***** | ***** | ***** |
| Metrics | ***** | ***** | ***** | ***** | ***** |
|---|---|---|---|---|---|
| Liquidity | |||||
| Current Ratio | ***** | ***** | ***** | ***** | ***** |
| Quick Ratio | ***** | ***** | ***** | ***** | ***** |
| Cash Ratio | ***** | ***** | ***** | ***** | ***** |
| Efficiency | |||||
| Inventory Days | ***** | ***** | ***** | ***** | ***** |
| Debtor Days | ***** | ***** | ***** | ***** | ***** |
| Creditor Days | ***** | ***** | ***** | ***** | ***** |
| Cash Conversion Cycle | ***** | ***** | ***** | ***** | ***** |
| Asset Turnover | ***** | ***** | ***** | ***** | ***** |
| Profitability | |||||
| Net Profit Margin % | ***** | ***** | ***** | ***** | ***** |
| Operating Margin % | ***** | ***** | ***** | ***** | ***** |
| ROE % | ***** | ***** | ***** | ***** | ***** |
| ROCE % | ***** | ***** | ***** | ***** | ***** |
| Net Worth Margin % | ***** | ***** | ***** | ***** | ***** |
| Growth | |||||
| Revenue Growth % | ***** | ***** | ***** | ***** | ***** |
| Leverage | |||||
| Equity Multiplier | ***** | ***** | ***** | ***** | ***** |
| Debt / EBITDA | ***** | ***** | ***** | ***** | ***** |
| Solvency | |||||
| D/E Ratio | ***** | ***** | ***** | ***** | ***** |
| ICR | ***** | ***** | ***** | ***** | ***** |
Consolidated Statements
Income Statement, Balance Sheet, Cash Flow & Ratios available in the full report.
Shareholding Pattern of Comofi Medtech Private Limited
As of FY 2023, Comofi Medtech Private Limited's shareholding pattern shows 100.00% by promoters. The promoters hold a majority stake, indicating strong promoter control.
| Year | 2025 |
|---|---|
| Promoters | 33.19% |
| DII | 23.22% |
| FII | 18.28% |
| Public | 22.89% |
| Others | 2.42% |
Charges & Borrowings Comofi Medtech Private Limited
Comofi Medtech Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Comofi Medtech Private Limited
View historical data on people associated with Comofi Medtech Private Limited, including employment history and EPFO contributions.
Employee Count & EPFO Data of Comofi Medtech Private Limited
Access employee headcount trends, monthly PF payment records, EPFO establishment details, and compliance data.
GST Compliance of Comofi Medtech Private Limited
GSTIN & GST Filing Data of Comofi Medtech Private Limited
Access GSTIN registrations, state-wise filing compliance, HSN/SAC codes, and detailed goods & services data.
Credit Ratings, Litigation & Regulatory Alerts for Comofi Medtech Private Limited
Credit Ratings, Legal Cases & Regulatory Alerts of Comofi Medtech Private Limited
Access complete credit rating history, litigation records, regulatory alerts, and compliance data.
MSME Payment Delays by Comofi Medtech Private Limited
MSME Payment Delays by Comofi Medtech Private Limited
Track payments outstanding to micro and small enterprise vendors, as disclosed in half-yearly MSME-1 returns filed with the MCA.
Subsidiaries & Group Companies of Comofi Medtech Private Limited
Subsidiaries & Group Companies of Comofi Medtech Private Limited
See the full corporate group - holding company, subsidiaries, associates and joint ventures of Comofi Medtech Private Limited with ownership details.
MCA Filings & Documents of Comofi Medtech Private Limited
MCA Filings & Documents of Comofi Medtech Private Limited
Download official documents filed with the Ministry of Corporate Affairs - from incorporation papers to the latest annual filings.
Recent Activity on Comofi Medtech Private Limited
Frequently Asked Questions about Comofi Medtech Private Limited
Comofi Medtech Private Limited is an active private limited company in the healthcare sector based in Bangalore, Karnataka, India. It was incorporated on 17 January 2018 (8+ years old) and is registered under CIN U33309KA2018PTC109614.
The current directors of Comofi Medtech Private Limited are:
The primary industry of Comofi Medtech Private Limited is healthcare. The company specifically operates in diagnostic centers and pathology labs. The company is currently active in this sector.
Yes, Comofi Medtech Private Limited is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Comofi Medtech Private Limited can be reached at the registered office: 358164437413 Jakkur Road Shivanahalli Village Yelahanka Hobli Bangalore North Taluk, Karnataka, India – 560064, or through the website comofimedtech.com.
The authorised capital is ₹10.5 Lakh, and the paid-up capital is ₹3.29 Lakh.